![Nanocarriers for ocular drug delivery: current status and translational opportunity - RSC Advances (RSC Publishing) DOI:10.1039/D0RA04971A Nanocarriers for ocular drug delivery: current status and translational opportunity - RSC Advances (RSC Publishing) DOI:10.1039/D0RA04971A](https://pubs.rsc.org/image/article/2020/RA/d0ra04971a/d0ra04971a-f2_hi-res.gif)
Nanocarriers for ocular drug delivery: current status and translational opportunity - RSC Advances (RSC Publishing) DOI:10.1039/D0RA04971A
![Trends in clinical trials for stroke by cell therapy: data mining ClinicalTrials.gov and the ICTRP portal site | npj Regenerative Medicine Trends in clinical trials for stroke by cell therapy: data mining ClinicalTrials.gov and the ICTRP portal site | npj Regenerative Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41536-019-0082-7/MediaObjects/41536_2019_82_Fig3_HTML.png)
Trends in clinical trials for stroke by cell therapy: data mining ClinicalTrials.gov and the ICTRP portal site | npj Regenerative Medicine
![Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity - ScienceDirect Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124720302928-fx1.jpg)
Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity - ScienceDirect
![Route of administration how drug gets in the body enteral=mouth/rectum parenteral=GI bypass PO---by mouth NG---nasogastric SL--sublingual buccal----cheek. - ppt download Route of administration how drug gets in the body enteral=mouth/rectum parenteral=GI bypass PO---by mouth NG---nasogastric SL--sublingual buccal----cheek. - ppt download](https://slideplayer.com/9035537/27/images/slide_1.jpg)
Route of administration how drug gets in the body enteral=mouth/rectum parenteral=GI bypass PO---by mouth NG---nasogastric SL--sublingual buccal----cheek. - ppt download
![Vaccines | Free Full-Text | Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies | HTML Vaccines | Free Full-Text | Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies | HTML](https://www.mdpi.com/vaccines/vaccines-09-00409/article_deploy/html/images/vaccines-09-00409-g003.png)
Vaccines | Free Full-Text | Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies | HTML
![The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice | SpringerLink The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00262-018-02294-5/MediaObjects/262_2018_2294_Fig3_HTML.png)
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice | SpringerLink
![Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial - The Lancet Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/98beeac6-283d-4536-bc93-0d79f5e4c7b2/gr2.jpg)